Literature DB >> 25482328

Quinine enhances the behavioral stimulant effect of cocaine in mice.

Adriana Huertas1, William D Wessinger2, Yuri V Kucheryavykh3, Priscila Sanabria4, Misty J Eaton5, Serguei N Skatchkov6, Legier V Rojas7, Gerónimo Maldonado-Martínez8, Mikhail Y Inyushin9.   

Abstract

The Na(+)-dependent dopamine transporter (DAT) is primarily responsible for regulating free dopamine (DA) concentrations in the brain by participating in the majority of DA uptake; however, other DA transporters may also participate, especially if cocaine or other drugs of abuse compromise DAT. Recently, such cocaine-insensitive low-affinity mono- and poly-amine OCT transporters were described in astrocytes which use DA as a substrate. These transporters are from a different transporter family and while insensitive to cocaine, they are specifically blocked by quinine and some steroids. Quinine is inexpensive and is often found in injected street drugs as an "adulterant". The present study was designed to determine the participation of OCTs in cocaine dependent behavioral and physiological changes in mice. Using FVB mice we showed, that daily single injections of quinine (10 mg/kg, i.p.) co-administered with cocaine (15 mg/kg, i.p.) for 10 days significantly enhanced cocaine-induced locomotor behavioral sensitization. Quinine had no significant effect on the time course of behavioral activation. In astrocytes from the ventral tegmental area of mice, transporter currents of quinine-sensitive monoamine transporters were also augmented after two weeks of cocaine administration. The importance of low-affinity high-capacity transporters for DA clearance is discussed, explaining the known ability of systemically administered DAT inhibitors to anomalously increase DA clearance.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine; Locomotor behavioral activation; Low affinity transporters; Quinine; Transporter current

Mesh:

Substances:

Year:  2014        PMID: 25482328      PMCID: PMC4356011          DOI: 10.1016/j.pbb.2014.11.021

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  62 in total

1.  Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes.

Authors:  Masato Inazu; Hiroshi Takeda; Teruhiko Matsumiya
Journal:  J Neurochem       Date:  2003-01       Impact factor: 5.372

2.  Electrochemical, pharmacological and electrophysiological evidence of rapid dopamine release and removal in the rat caudate nucleus following electrical stimulation of the median forebrain bundle.

Authors:  J Millar; J A Stamford; Z L Kruk; R M Wightman
Journal:  Eur J Pharmacol       Date:  1985-03-12       Impact factor: 4.432

Review 3.  Bogus heroin.

Authors:  J M Dillmann
Journal:  J Emerg Nurs       Date:  1997-10       Impact factor: 1.836

4.  Inducible, brain region-specific expression of a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity to cocaine.

Authors:  M-C Peakman; C Colby; L I Perrotti; P Tekumalla; T Carle; P Ulery; J Chao; C Duman; C Steffen; L Monteggia; M R Allen; J L Stock; R S Duman; J D McNeish; M Barrot; D W Self; E J Nestler; E Schaeffer
Journal:  Brain Res       Date:  2003-04-25       Impact factor: 3.252

5.  Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1.

Authors:  P Arndt; C Volk; V Gorboulev; T Budiman; C Popp; I Ulzheimer-Teuber; A Akhoundova; S Koppatz; E Bamberg; G Nagel; H Koepsell
Journal:  Am J Physiol Renal Physiol       Date:  2001-09

6.  An overview of heroin trends in New York City: past, present and future.

Authors:  B Frank
Journal:  Mt Sinai J Med       Date:  2000 Oct-Nov

7.  Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.

Authors:  J P Finberg; J Wang; D S Goldstein; I J Kopin; K S Bankiewicz
Journal:  J Neurochem       Date:  1995-09       Impact factor: 5.372

8.  Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.

Authors:  A E Busch; U Karbach; D Miska; V Gorboulev; A Akhoundova; C Volk; P Arndt; J C Ulzheimer; M S Sonders; C Baumann; S Waldegger; F Lang; H Koepsell
Journal:  Mol Pharmacol       Date:  1998-08       Impact factor: 4.436

9.  Cocaine use increases [3H]WIN 35428 binding sites in human striatum.

Authors:  K Y Little; J A Kirkman; F I Carroll; T B Clark; G E Duncan
Journal:  Brain Res       Date:  1993-11-19       Impact factor: 3.252

10.  Low or high cocaine responding rats differ in striatal extracellular dopamine levels and dopamine transporter number.

Authors:  Anna M Nelson; Gaynor A Larson; Nancy R Zahniser
Journal:  J Pharmacol Exp Ther       Date:  2009-09-03       Impact factor: 4.030

View more
  2 in total

1.  Antioxidant and Anti-Apoptotic Activity of Octadecaneuropeptide Against 6-OHDA Toxicity in Cultured Rat Astrocytes.

Authors:  Hadhemi Kaddour; Yosra Hamdi; Fatma Amri; Seyma Bahdoudi; Ibtissem Bouannee; Jérôme Leprince; Sami Zekri; Hubert Vaudry; Marie-Christine Tonon; David Vaudry; Mohamed Amri; Sana Mezghani; Olfa Masmoudi-Kouki
Journal:  J Mol Neurosci       Date:  2018-10-20       Impact factor: 3.444

2.  Protective Effect of Quinine on Chemical Kindling and Passive Avoidance Test in Rats.

Authors:  Zahra Faridkia; Parichehr Yaghmaei; Marjan Nassiri-Asl
Journal:  Iran Red Crescent Med J       Date:  2016-08-21       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.